Correlation Between Eastwood Bio and Thomson Reuters

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eastwood Bio and Thomson Reuters at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eastwood Bio and Thomson Reuters into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eastwood Bio Medical Canada and Thomson Reuters Corp, you can compare the effects of market volatilities on Eastwood Bio and Thomson Reuters and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eastwood Bio with a short position of Thomson Reuters. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eastwood Bio and Thomson Reuters.

Diversification Opportunities for Eastwood Bio and Thomson Reuters

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eastwood and Thomson is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Eastwood Bio Medical Canada and Thomson Reuters Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Thomson Reuters Corp and Eastwood Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eastwood Bio Medical Canada are associated (or correlated) with Thomson Reuters. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Thomson Reuters Corp has no effect on the direction of Eastwood Bio i.e., Eastwood Bio and Thomson Reuters go up and down completely randomly.

Pair Corralation between Eastwood Bio and Thomson Reuters

Assuming the 90 days horizon Eastwood Bio Medical Canada is expected to generate 22.86 times more return on investment than Thomson Reuters. However, Eastwood Bio is 22.86 times more volatile than Thomson Reuters Corp. It trades about 0.08 of its potential returns per unit of risk. Thomson Reuters Corp is currently generating about 0.04 per unit of risk. If you would invest  60.00  in Eastwood Bio Medical Canada on September 22, 2024 and sell it today you would lose (6.00) from holding Eastwood Bio Medical Canada or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eastwood Bio Medical Canada  vs.  Thomson Reuters Corp

 Performance 
       Timeline  
Eastwood Bio Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eastwood Bio Medical Canada has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Eastwood Bio is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Thomson Reuters Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Thomson Reuters Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy forward indicators, Thomson Reuters is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Eastwood Bio and Thomson Reuters Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eastwood Bio and Thomson Reuters

The main advantage of trading using opposite Eastwood Bio and Thomson Reuters positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eastwood Bio position performs unexpectedly, Thomson Reuters can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thomson Reuters will offset losses from the drop in Thomson Reuters' long position.
The idea behind Eastwood Bio Medical Canada and Thomson Reuters Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities